NCT02858518 Risk of Bleeding and Anticoagulation in Atrial Fibrillation: What Predictive Criterion Used? Status COMPLETED Phase N/A
NCT02856633 Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station Status COMPLETED Phase N/A
NCT02856191 Study on the Frequency of de Novo Atrial Fibrillation in Septic Shock in Medical Intensive Care Status COMPLETED Phase NA
NCT02846922 Catheter Ablation and Rate Control of Atrial Fibrillation in Patients With Heart Failure Status COMPLETED Phase N/A
NCT02844959 Inflammatory Response as a Prognostic Factor of Recurrence of Atrial Fibrillation After Ablation Status UNKNOWN Phase N/A
NCT02843516 Detection Rate of Atrial Fibrillation in Patients Implanted With ILRs Status COMPLETED Phase N/A
NCT02841475 Factors Associated to the Instability of the INR (International Normalized Ratio ) in the Prevention of Thromboembolism AVK (Anti Vitamin K) in Atrial Fibrillation in the Elderly: Instead of Comorbidities Status COMPLETED Phase N/A
NCT02839746 Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF) Status COMPLETED Phase N/A
NCT02839304 Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation Status COMPLETED Phase NA
NCT02834221 Ultrasound-guided Femoral Vein Accessibility, Safety and Time for Atrial Fibrillation Treatment Status COMPLETED Phase NA
NCT02832206 Hybrid Ablation of Persistent and Long-standing Persistent Stand-alone Atrial Fibrillation Status COMPLETED Phase N/A
NCT02832089 Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation Status COMPLETED Phase PHASE3
NCT02830152 Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage Status ACTIVE_NOT_RECRUITING Phase NA
NCT02817776 Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF) Status COMPLETED Phase NA